Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jincai, Zhong"'
Autor:
Zhe-Yu Hu, Min Yan, Huihua Xiong, Li Ran, Jincai Zhong, Ting Luo, Tao Sun, Ning Xie, Liping Liu, Xiaohong Yang, Huawu Xiao, Jing Li, Binliang Liu, Quchang Ouyang
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-10 (2023)
Abstract Background Human epidermal growth factor receptor 2 (HER2) targeted therapy combined with endocrine therapy has been recommended as an alternative treatment strategy for patients with hormone receptor (HR)-positive, HER2-positive metastatic
Externí odkaz:
https://doaj.org/article/945eca1f6a834632920aa7e7321a30fe
Publikováno v:
Frontiers in Molecular Biosciences, Vol 8 (2021)
Immune-related genes (IRGs) are closely related to tumor progression and the immune microenvironment. Few studies have investigated the effect of tumor immune microenvironment on the survival and response to immune checkpoint inhibitors of patients w
Externí odkaz:
https://doaj.org/article/9b0e51a893134e1593e23ec1d1cb5f29
Autor:
Pin Zhang, Qingyuan Zhang, Zhongsheng Tong, Tao Sun, Wei Li, Quchang Ouyang, Xichun Hu, Ying Cheng, Min Yan, Yueyin Pan, Yuee Teng, Xi Yan, Ying Wang, Weimin Xie, Xiaohua Zeng, Xiaojia Wang, Changlu Hu, Cuizhi Geng, Hongwei Zhang, Wenxin Li, Xinhong Wu, Jincai Zhong, Jingwei Xu, Yanxia Shi, Wenhua Wei, Nayima Bayaxi, Xiaoyu Zhu, Binghe Xu
Publikováno v:
The Lancet Oncology. 24:646-657
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ded28f350576f6aa06f02b748c01f8c
https://doi.org/10.1016/s1470-2045(23)00172-9
https://doi.org/10.1016/s1470-2045(23)00172-9
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 1, Pp 100112- (2021)
Externí odkaz:
https://doaj.org/article/192e19fd40bf43459c0f0db3792d9bf3
Autor:
Fei Ma, Min Yan, Wei Li, Quchang Ouyang, Zhongsheng Tong, Yuee Teng, Yongsheng Wang, Shusen Wang, Cuizhi Geng, Ting Luo, Jincai Zhong, Qingyuan Zhang, Qiang Liu, Xiaohua Zeng, Tao Sun, Qinguo Mo, Hu Liu, Ying Cheng, Jing Cheng, Xiaojia Wang
Publikováno v:
BMJ: British Medical Journal; 11/4/2023, Vol. 383 Issue 8405, p1-10, 10p
Autor:
Quchang Ouyang, Huihua Xiong, Min Yan, Jincai Zhong, Li Ran, Ting Luo, Liping Liu, Jing Li, Xiaohong Yang, Huawu Xiao, Ning Xie, Hui Wu, Jianxiang Gao, Jun Lu, Xuming Hu, Zheyu Hu, Can Tian, Zhengrong Shui, Min Cao
Publikováno v:
Cancer Research. 82:P2-13
Background: HER2-targeted agents combined with endocrine therapy (ET) has been recommended as an optional therapeutic strategy for hormone receptor (HR)/human epidermal growth factor receptor 2 (HER2) co-positive metastatic breast cancer (MBC). Pyrot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1cb16920b564f83df294413850f87e13
https://doi.org/10.1158/1538-7445.sabcs21-p2-13-32
https://doi.org/10.1158/1538-7445.sabcs21-p2-13-32
Publikováno v:
Medicine; 7/7/2023, Vol. 102 Issue 27, p1-4, 4p
Publikováno v:
Minerva Medica.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07a8e655661577ca863ba833b198a9ce
https://doi.org/10.23736/s0026-4806.22.08296-9
https://doi.org/10.23736/s0026-4806.22.08296-9
Autor:
Yuan-Qi Zhang, Heng Huang, Anqin Zhang, Ying Lin, Yuhua Song, Zhen Shan, Hongmin Ma, Jianwen Li, Li Cai, Rui Zhuo, Zhiyong Wu, Xiangyang Song, Zhongyu Yuan, Lehong Zhang, Li Zhao, Nan Shao, Ailing Zhang, Jincai Zhong, Herui Yao, Weixiong Yang, Qian-Jun Chen, Kun Wang, Feihai Ling, Hui Liu
Publikováno v:
Cancer Research. 80:OT1-04
In SOFT study, subgroup analysis for hormone receptor-positive (HR+) breast cancer women younger than 35 years indicated better 5-year DFS in OFS+exemestane arm than OFS+tamoxifen. Since only about 11% of women included were younger than 35 years of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d553167cbb35f19536a76618d3f0bf19
https://doi.org/10.1158/1538-7445.sabcs19-ot1-04-01
https://doi.org/10.1158/1538-7445.sabcs19-ot1-04-01
Publikováno v:
Medicine. 100(30)
This study aimed to investigate the prognostic factors of patients after liver cancer surgery and evaluate the predictive power of nomogram. Liver cancer patients with the history of surgery in the Surveillance, Epidemiology, and End Results database
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f35f684d4c39f2b52f7e45d9b09cfd5a
https://pubmed.ncbi.nlm.nih.gov/34397696
https://pubmed.ncbi.nlm.nih.gov/34397696